|« Previous month||Next month »|
30-Aug-2012 - Hospira has bought Orchid Chemicals and Pharmaceutical’s active pharmaceutical ingredient (API) facility in Aurangabad, India, to support its expanding antibiotic business.
30-Aug-2012 - Regulatory professionals working for contract research organisations (CROs) in emerging markets could benefit from taking a test to bring them up to par with those in developed countries, according to...
30-Aug-2012 - QPS has boosted its late phase offering after acquiring Austrian-based JSW Life Sciences.
30-Aug-2012 - Outsourcing-Pharma.com presents its weekly round-up of the latest chops and changes in the world of pharmaceuticals, including news from INC Research, Y-Prime and Ariana.
29-Aug-2012 - The PRACS Institute has sold its Miami, US facility to a new early-phase focused CRO, CRI Phase I Corporation.
29-Aug-2012 - The lack of competing studies, proximity to the SFDA HQ and were the key drivers for the new Beijing, China office according to PRA International.
29-Aug-2012 - GlaxoSmithKline (GSK) and AstraZeneca have been attracted by NHS efforts to work with sponsors and CROs outside the UK according to Government investment group, UK Trade and Investment.
29-Aug-2012 - Charles River Laboratories has acquired Accugenix in a bid to expand its endotoxin and microbial detection portfolio.
28-Aug-2012 - United Drug (UD) has bought firms in the pharmacovigilance and market access sectors, following up on its acquisition in the contract packaging industry last week.
28-Aug-2012 - The UK’s National Health Service (NHS) has launched plans to provide services to the pharmaceutical industry internationally.
28-Aug-2012 - Health economics and outcomes research teams must have a greater influence over clinical trial design if pharma firms are to achieve reimbursement goals, according to Cutting Edge Information.
28-Aug-2012 - CROs conducting bioequivalence and bioavailability (BE/BA) studies for generics firms will have to log details of their sites with the US FDA under new ‘self-identification’ rules.
27-Aug-2012 - India’s IT sector must expand its knowledge base to fully meet the surge in demand for biostatistics says Alticure Research.
27-Aug-2012 - US Injectable drugmaker Hospira will invest $85m and create 200 new jobs at its plant in Rocky Mount, North Carolina according to the State Governor.
27-Aug-2012 - Precos will expand its portfolio of preclinical cancer models after being licensed to store and handle human tissue by the UK’s HTA.
24-Aug-2012 - Cobra Biologics claims a new micro bioreactor technology it has adopted can cut three months off cell line development timelines and facilitate faster production scale-up.
23-Aug-2012 - Comprehend Systems recently made its data analytics, visualisations and reports software available from the cloud. CEO Rick Morrison spoke with Outsourcing-Pharma.com about the firm’s reasoning, and why no rockets were...
23-Aug-2012 - Bend Research can now work with high-potency (HP) ingredients thanks to a new spray-drying facility.
23-Aug-2012 - United Drug wants the US courts to throw out accusations it disclosed confidential data about Catalent’s packaging business after secret acquisition talks collapsed last year.
22-Aug-2012 - West Pharmaceutical Services has started construction of a facility in Sri City, India, citing growing importance of the Asia-Pacific market.
22-Aug-2012 - ShangPharma saw a $10m lift in its Q2 revenues bolstered by increased business from its top ten clients.
22-Aug-2012 - German CRO Verum.de wants to win business from US and North American sponsors keen to conduct trials in central and Eastern Europe (CEE).
21-Aug-2012 - United Drug will buy the UK and US trial supply businesses of Indian contractor Bilcare to further expand its packaging services division.
21-Aug-2012 - Genomic analysis seems to be an area of interest for the contract services sector at the moment with Northern Ireland-based Almac and US CRO Quintiles only the latest firms to...
|« Previous month||Next month »|